Graduate Education
How to Become a Student at the Walter and Eliza Hall Institute of Medical Research
Post-graduate research training is one of the Institute’s core responsibilities, primarily (but not exclusively) exercised through its role as the Department of Medical Biology of The University of Melbourne. Students are accepted for PhD, BSc Honours and Advanced Medical Science degrees. The Institute seeks out the brightest science and medical graduates and provides them with world-class training and facilities, strong mentorship and cutting-edge projects. Students also gain from diverse opportunities to gain skills in leadership and communication. The high achievements of our graduates ensures their entry into prestigious laboratories overseas for further training and experience.
Read more
Living in Melbourne
Melbourne is widely regarded as the biotech, cultural, sporting and culinary capital of Australia and offers a vibrant and cosmopolitan lifestyle.
Read more
Our Culture
The Walter and Eliza Hall Institute of Medical Research is well-established to nurture and develop up and coming talented researchers through Honours and PhD programs across 8 research divisions.
Read more
Scholarships
PhD students who are accepted by the Institute must gain their own scholarships. Note that the deadline for scholarships is August for NHMRC; August for IPRS/MIFRS; and October for APA/MRS in the year prior.
Read more
WESA – The Walter and Eliza Hall Student Association
The Walter and Eliza Hall Student Association (WESA) represent the student body in academic issues and, more importantly, make student life a lot more interesting. Activities include invited speakers, weekly sport, movie nights, pub nights and the all-famous Annual Student Retreat.
Read more
WEHI Open Days
Do you wish to become a UROP, Honours, AMS, PhD or foreign internship student in a leading biomedical research institute? The Walter and Eliza Hall Institute has for more than 90 years investigated the causes of cancer, autoimmunity and infectious diseases, and has embarked in an ambitious long-term program to develop new treatments against leukaemia, breast cancer, diabetes and malaria.
Read more